Future of diabetes care will be about data
Insulin dosing and glucose level monitoring data combined in one platform is the object of two major partnerships focusing on diabetes.
Insulin dosing and glucose level monitoring data combined in one platform is the object of two major partnerships focusing on diabetes.
Alongside receiving a priority review designation for its Ebola vaccine, Merck revealed that it planned to produce 650,000 additional doses.